SCHEMBL25002929

SCHEMBL25002929

COC(=O)c1cccc(-c2ccc(OC)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.52
CTSA P10619 2/20 0.52
KDM4E B2RXH2 3/20 0.51
GAA P10253 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 1/20 0.51
NPC1 O15118 1/20 0.51
LMNA P02545 1/20 0.51
ALPL P05186 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PARP1 P09874 1/20 0.50
PLA2G2A P14555 1/20 0.50
SCN9A Q15858 1/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1179838 0.88 CYP11B1 (0.56) KDM4EGAAMAPTNPC1LMNA
SCHEMBL3711274 0.87 MCL1 (0.55) GAAMAPTSMN1; SMN2SCN9AALDH1A1
SCHEMBL483444 0.86 MAPT (0.56) GAAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL28473632 0.86 PARP1 (0.51) ADORA3CTSAKDM4EGAAKMT2A
SCHEMBL30614602 0.86 MCL1 (0.60) ADORA3CTSAKDM4EGAAKMT2A
SCHEMBL4630405 0.86 MCL1 (0.60) ADORA3CTSAKDM4EGAAKMT2A
SCHEMBL25002893 0.85 NPC1 (0.55) ADORA3CTSAKDM4EMAPTNPC1
SCHEMBL4591255 0.85 SCN10A (0.65) ADORA3KDM4EMAPTSCN9AALDH1A1
SCHEMBL25002928 0.85 MCL1 (0.54) CTSAKDM4EGAAKMT2AMAPT
SCHEMBL1260197 0.85 ALDH1A1 (0.52) ADORA3KDM4EGAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 WO disclosed